SCHEMBL5118975

SCHEMBL5118975

O=C(O)CCCCCc1ccc(Cn2cc(Br)c(=O)[nH]c2=O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DTYMK P23919 1/20 1.00
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5129605 0.99 DTYMK (0.98) DTYMKMEN1KMT2A
SCHEMBL14208526 0.95 DTYMK (0.91) DTYMKMEN1KMT2A
SCHEMBL5125087 0.90 DTYMK (0.82) DTYMKMEN1KMT2A
SCHEMBL5119096 0.88 DTYMK (0.78) DTYMK
SCHEMBL5125422 0.85 DTYMK (0.74) DTYMK
SCHEMBL14208557 0.85 DTYMK (0.74) DTYMKMEN1KMT2A
SCHEMBL5126818 0.84 DTYMK (0.72) DTYMK
SCHEMBL14208545 0.82 DTYMK (0.70) DTYMK
SCHEMBL5125108 0.80 DTYMK (0.67) DTYMK
SCHEMBL5123271 0.79 DTYMK (0.64) DTYMKKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096907-A1 Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents INSTITUT PASTEUR (FR) 2008-04-24 US disclosed
US-20080096907-A1 Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents INSTITUT PASTEUR (FR) 2008-04-24 US disclosed
US-20080096907-A1 Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents INSTITUT PASTEUR (FR) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096907-A1 Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents TPMT, DHFR, TYMP DTYMK 209/4885MEN1 4142/4885KMT2A 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.